Live demo to learn all about this revolutionary treatment - Coolsculpting

« Prev

Next »

Live demo to learn all about this revolutionary treatment - Coolsculpting

Description:

Join us for a live demo to learn all about this revolutionary treatment and witness how easy and comfortable it is to lose unsightly, unwanted body fat.
CoolSculpting is a non-invasive, non-surgical, fat-freezing procedure that is FDA-cleared for eliminating stubborn body fat, and may be just what you need to achieve the look of your dreams.

-This simple and effective treatment can be done during your lunch break.
-Since there is no downtime, you can return immediately to your daily activities.
-This comfortable procedure does not require any numbing agents or anesthesia, allowing you to read a book or answer e-mails during your CoolSculpting session.

Complimentary lunch and refreshments will be provided during the demo!

Admission is FREE and seats are limited! Please RSVP to
972-265-1590
Rejuve Med-Spa
18220 Preston Road, Dallas TX 75252

About Rejuve:
Rejuve Med-Spa is the premier luxury medical spa in North Dallas. Rejuve provides the most advanced, minimally invasive, results oriented aesthetic treatments in a safe and luxurious spa environment, with an exceptional level of customer service.

The CoolSculpting fat-freezing procedure is the only FDA-cleared, non-surgical fat-reduction treatment that uses controlled cooling to eliminate stubborn fat that resists all efforts through diet and exercise. The results are proven, noticeable and lasting - so you'll look great from every angle. https://rejuvemedspa.com/service/coolsculpting

General details:

Sold by: Taylor Clayton (0 / # 0) Grade Taylor Clayton
Email: rejuvemedspatx@gmail.com

Ad Details

Ad id: 340756
Ad views:86
Ad expires: 2018.11.09 (in 22 days)
Added: 2018.10.10
Current rating (after 0 votes) Grade






More ads in this category Ads from this seller Contact seller Tell-a-friend Print

Search
   

We have a total of 141057 users and 7560 ads. There have been 1901368 ad views.